Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Ridge

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Molecular Carcinogenesis|September 6, 2001
Elevated furin expression in aggressive human head and neck tumors and tumor cell linesD E Bassi, H Mahloogi, L Al-Saleem, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1995
Pretreatment hemoglobin level influences local control and survival of T1-T2 squamous cell carcinomas of the glottic larynxD A Fein, W R Lee, A L Hanlon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 11, 2016
Causes of death among cancer patientsN G Zaorsky, T M Churilla, B L Egleston, et al.
Annals of Surgery|September 1, 1985
Predicting tumor response in patients with colorectal hepatic metastasesJ M Daly, J Butler, N Kemeny, et al.
Cancer Research|October 1, 1994
Higher frequency of alterations in the p16/CDKN2 gene in squamous cell carcinoma cell lines than in primary tumors of the head and neckS Y Zhang, A J Klein-Szanto, E R Sauter, et al.
Head & Neck|July 15, 1998
Phase II study of N-phosphonacetyl-L-aspartate, recombinant interferon-alpha, and fluorouracil infusion in advanced squamous cell carcinoma of the head and neckC J Langer, D Schaebler, E Sauter, et al.
International Journal of Radiation Oncology, Biology, Physics|August 5, 2000
A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003K K Fu, T F Pajak, A Trotti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2004
Preliminary results of Radiation Therapy Oncology Group 97-03: a randomized phase ii trial of concurrent radiation and chemotherapy for advanced squamous cell carcinomas of the head and neckA S Garden, J Harris, E E Vokes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 11, 2014
Induction cetuximab, paclitaxel, and carboplatin followed by chemoradiation with cetuximab, paclitaxel, and carboplatin for stage III/IV head and neck squamous cancer: a phase II ECOG-ACRIN trial (E2303)H J Wanebo, J Lee, B A Burtness, et al.
International Journal of Radiation Oncology, Biology, Physics|October 20, 2001
Radiation Therapy Oncology Group. Research Plan 2002-2006. Head and Neck Cancer CommitteeK Ang, R Weber, E Vokes, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Molecular Carcinogenesis|September 6, 2001
Elevated furin expression in aggressive human head and neck tumors and tumor cell linesD E Bassi, H Mahloogi, L Al-Saleem, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1995
Pretreatment hemoglobin level influences local control and survival of T1-T2 squamous cell carcinomas of the glottic larynxD A Fein, W R Lee, A L Hanlon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 11, 2016
Causes of death among cancer patientsN G Zaorsky, T M Churilla, B L Egleston, et al.
Annals of Surgery|September 1, 1985
Predicting tumor response in patients with colorectal hepatic metastasesJ M Daly, J Butler, N Kemeny, et al.
Cancer Research|October 1, 1994
Higher frequency of alterations in the p16/CDKN2 gene in squamous cell carcinoma cell lines than in primary tumors of the head and neckS Y Zhang, A J Klein-Szanto, E R Sauter, et al.
Head & Neck|July 15, 1998
Phase II study of N-phosphonacetyl-L-aspartate, recombinant interferon-alpha, and fluorouracil infusion in advanced squamous cell carcinoma of the head and neckC J Langer, D Schaebler, E Sauter, et al.
International Journal of Radiation Oncology, Biology, Physics|August 5, 2000
A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003K K Fu, T F Pajak, A Trotti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2004
Preliminary results of Radiation Therapy Oncology Group 97-03: a randomized phase ii trial of concurrent radiation and chemotherapy for advanced squamous cell carcinomas of the head and neckA S Garden, J Harris, E E Vokes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 11, 2014
Induction cetuximab, paclitaxel, and carboplatin followed by chemoradiation with cetuximab, paclitaxel, and carboplatin for stage III/IV head and neck squamous cancer: a phase II ECOG-ACRIN trial (E2303)H J Wanebo, J Lee, B A Burtness, et al.
International Journal of Radiation Oncology, Biology, Physics|October 20, 2001
Radiation Therapy Oncology Group. Research Plan 2002-2006. Head and Neck Cancer CommitteeK Ang, R Weber, E Vokes, et al.
Pageof 6